Skip to main content
Fig. 3 | BMC Veterinary Research

Fig. 3

From: Pharmacokinetic and urinary profiling reveals the prednisolone/cortisol ratio as a valid biomarker for prednisolone administration

Fig. 3

Urinary concentration profile of 20β-dihydroprednisolone during growth-promoting and ACTH administration. Concentrations of 20β-dihydroprednisolone (20β-DHP) are log-transformed and presented for the oral (PO1) and intramuscular (IM1) growth-promoting treatment, as well as for the ACTH treatment (with sampling moments at 4 h and 6 h after administration)

Back to article page

BMC Veterinary Research

ISSN: 1746-6148

Contact us